Idarubicin plus continuous-infusion high-dose cytarabine as treatment for patients with acute myelogenous leukemia or myelodysplastic syndrome. [electronic resource]
Producer: 19940218Description: 1-5 p. digitalISSN:- 0093-7754
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Cytarabine -- administration & dosage
- Drug Administration Schedule
- Humans
- Idarubicin -- administration & dosage
- Leukemia, Myeloid, Acute -- drug therapy
- Middle Aged
- Myelodysplastic Syndromes -- drug therapy
- Remission Induction
- Survival Rate
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.